raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:86849

Acute basophilic leukemia

Type
Disease
Group
Disorder
Age of onset
All ages
Status
active

A rare acute myeloid leukemia characterized by primary differentiation to basophils. Microscopically, peripheral blood and bone marrow blasts contain coarse cytoplasmic basophilic granules which are positive with metachromatic staining (toluidine blue). Electron microscopy confirms that granules show features characteristic of basophil precursors. Mature basophils are usually sparse. Patients may present with manifestations related to bone marrow failure, as well as hepatosplenomegaly, cutaneous involvement, lytic lesions, and hyperhistaminemia. The disease is associated with a poor prognosis.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute basophilic leukemia
frLeucémie aiguë à basophiles
deLeukämie, akute basophile
esLeucemia basofílica aguda
itLeucemia basofila acuta
nlAcute basofiele leukemie
ptLeucemia basofílica aguda
plOstra białaczka bazofilowa
csAkutní bazofilní leukémie
ukГострий базофільний лейкоз
zh急性嗜碱粒细胞白血病
trAkut bazofilik lösemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C94.7NTBTattributedvalidated
ICD-112A60.37Especificvalidated
MONDO0019458Evalidated
MeSHD015471Evalidated
UMLSC0023437Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GATA1Part of a fusion gene inAssessedHGNC:4170ENSG00000102145305371Xp11.23GATA binding protein 121474671[PMID]
MYBPart of a fusion gene inAssessedHGNC:7545ENSG000001185131899906q23.3MYB proto-oncogene, transcription factor21474671[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 000—EuropeClass onlyValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card